The National Institute of Neurological Disorders and Stroke (NINDS) invites grant applications for research on understanding and treating tuberous sclerosis complex (TSC). This announcement is made together with 4 other components of the National Institutes of Health (NIH).
TSC is a multi-system disease that causes benign tumors, or hamartomas, to form at multiple sites throughout the body. Hamartomas can develop in many different organs, primarily the brain, lungs, heart, kidney, skin, and eyes. There is no cure for TSC and treatment is symptomatic. A variety of mouse models of TSC are now available, providing an opportunity to understand the disease mechanisms and evaluate therapies.
For more information, potential applicants should contact Dr. Jane Fountain, Program Director, Neural Environment Cluster, NINDS; telephone: 301-496-1431; e-mail: firstname.lastname@example.org. For a more detailed description of this announcement, visit http://grants.nih.gov/grants/guide/pa-files/PAS-07-190.html.